Symposium 4: Assisted fertilization and maternal diabetes mellitus

Authors

  • Marisa Geller In Vitro Buenos Aires, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v56i3Sup.498

Keywords:

fertilization, diabetes mellitus

Abstract

Type 1 and 2 diabetes mellitus (DM) are among the most prevalent chronic diseases in women of reproductive age. In turn, they are patients with alterations in their fertility where it is observed that they have fewer offspring than their peers and several must undergo highly complex fertility treatments.

The hyperglycemia of DM1 (due to insulin deficiency) and hyperinsulinemia (due to exogenous administration) can induce hypogonadism, ovaries with a polycystic appearance and hyperandrogenism. In the case of DM2, patients may present with polycystic ovary syndrome (PCOS), obesity, insulin resistance and chronic inflammation, all of which explains the greater difficulty in achieving pregnancy.

Author Biography

Marisa Geller, In Vitro Buenos Aires, Autonomous City of Buenos Aires, Argentina

Medical Director of In Vitro Buenos Aires; Gynecologist Specialist in Reproductive Medicine

References

I. Due Larsen M, Moller Jenssen D. Live born children after assisted reproduction in women with type 1 diabetes and type 2 diabetes: a nation wide cohort study. Diabetologia 2020;63:1736-1744.

II. Facondo P, Di Lodovico E. The impact of diabetes mellitus type 1 on male fertility: systematic review and meta-analysis. Andrology 2022;10:426-440.

III. Zymperdikas C, Zymperdikas V. Assisted reproduction technology outcomes in women with infertility and preexisting diabetes mellitus: a systematic review. Hormones 2022;21:23-31.

Published

2022-09-01

How to Cite

Geller, M. (2022). Symposium 4: Assisted fertilization and maternal diabetes mellitus. Journal of the Argentine Society of Diabetes, 56(3Sup), 13–13. https://doi.org/10.47196/diab.v56i3Sup.498

Most read articles by the same author(s)